Cardinal Health Statistics
Total Valuation
Cardinal Health has a market cap or net worth of $63.32 billion. The enterprise value is $66.87 billion.
| Market Cap | 63.32B |
| Enterprise Value | 66.87B |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Oct 1, 2026 |
Share Statistics
Cardinal Health has 231.14 million shares outstanding. The number of shares has decreased by -2.08% in one year.
| Current Share Class | 231.14M |
| Shares Outstanding | 231.14M |
| Shares Change (YoY) | -2.08% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 91.07% |
| Float | 230.70M |
Valuation Ratios
The trailing PE ratio is 35.47 and the forward PE ratio is 20.74. Cardinal Health's PEG ratio is 1.38.
| PE Ratio | 35.47 |
| Forward PE | 20.74 |
| PS Ratio | 0.25 |
| Forward PS | 0.23 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.92 |
| P/OCF Ratio | 11.31 |
| PEG Ratio | 1.38 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.24, with an EV/FCF ratio of 13.65.
| EV / Earnings | 36.79 |
| EV / Sales | 0.26 |
| EV / EBITDA | 15.24 |
| EV / EBIT | 19.57 |
| EV / FCF | 13.65 |
Financial Position
The company has a current ratio of 0.88
| Current Ratio | 0.88 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.88 |
| Debt / FCF | 1.80 |
| Interest Coverage | 10.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 3.72% |
| Return on Invested Capital (ROIC) | 20.50% |
| Return on Capital Employed (ROCE) | 25.86% |
| Weighted Average Cost of Capital (WACC) | 6.63% |
| Revenue Per Employee | $4.03M |
| Profits Per Employee | $28,451 |
| Employee Count | 63,900 |
| Asset Turnover | 4.49 |
| Inventory Turnover | 13.78 |
Taxes
In the past 12 months, Cardinal Health has paid $457.00 million in taxes.
| Income Tax | 457.00M |
| Effective Tax Rate | 20.19% |
Stock Price Statistics
The stock price has increased by +34.58% in the last 52 weeks. The beta is 0.52, so Cardinal Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +34.58% |
| 50-Day Moving Average | 241.27 |
| 200-Day Moving Average | 223.77 |
| Relative Strength Index (RSI) | 75.12 |
| Average Volume (20 Days) | 1,837,612 |
Short Selling Information
The latest short interest is 7.68 million, so 3.32% of the outstanding shares have been sold short.
| Short Interest | 7.68M |
| Short Previous Month | 6.67M |
| Short % of Shares Out | 3.32% |
| Short % of Float | 3.33% |
| Short Ratio (days to cover) | 4.16 |
Income Statement
In the last 12 months, Cardinal Health had revenue of $257.75 billion and earned $1.82 billion in profits. Earnings per share was $7.72.
| Revenue | 257.75B |
| Gross Profit | 10.05B |
| Operating Income | 3.42B |
| Pretax Income | 2.26B |
| Net Income | 1.82B |
| EBITDA | 4.39B |
| EBIT | 3.42B |
| Earnings Per Share (EPS) | $7.72 |
Balance Sheet
The company has $5.26 billion in cash and $8.82 billion in debt, with a net cash position of -$3.55 billion or -$15.36 per share.
| Cash & Cash Equivalents | 5.26B |
| Total Debt | 8.82B |
| Net Cash | -3.55B |
| Net Cash Per Share | -$15.36 |
| Equity (Book Value) | -2.87B |
| Book Value Per Share | -13.04 |
| Working Capital | -5.34B |
Cash Flow
In the last 12 months, operating cash flow was $5.60 billion and capital expenditures -$698.00 million, giving a free cash flow of $4.90 billion.
| Operating Cash Flow | 5.60B |
| Capital Expenditures | -698.00M |
| Depreciation & Amortization | 970.00M |
| Net Borrowing | -151.00M |
| Free Cash Flow | 4.90B |
| FCF Per Share | $21.20 |
Margins
Gross margin is 3.90%, with operating and profit margins of 1.33% and 0.71%.
| Gross Margin | 3.90% |
| Operating Margin | 1.33% |
| Pretax Margin | 0.88% |
| Profit Margin | 0.71% |
| EBITDA Margin | 1.70% |
| EBIT Margin | 1.33% |
| FCF Margin | 1.90% |
Dividends & Yields
This stock pays an annual dividend of $2.06, which amounts to a dividend yield of 0.75%.
| Dividend Per Share | $2.06 |
| Dividend Yield | 0.75% |
| Dividend Growth (YoY) | 1.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 26.72% |
| FCF Payout Ratio | 9.73% |
| Buyback Yield | 2.08% |
| Shareholder Yield | 2.83% |
| Earnings Yield | 2.82% |
| FCF Yield | 7.74% |
Analyst Forecast
The average price target for Cardinal Health is $291.53, which is 6.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $291.53 |
| Price Target Difference | 6.41% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 5.50% |
| EPS Growth Forecast (3Y) | 13.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on April 23, 2001. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 23, 2001 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Cardinal Health has an Altman Z-Score of 4.95 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.95 |
| Piotroski F-Score | 6 |